A detailed history of Measured Wealth Private Client Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Measured Wealth Private Client Group, LLC holds 2,313 shares of GILD stock, worth $226,650. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,313
Previous 2,450 5.59%
Holding current value
$226,650
Previous $205,000 3.9%
% of portfolio
0.07%
Previous 0.07%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

SELL
$83.95 - $97.9 $11,501 - $13,412
-137 Reduced 5.59%
2,313 $213,000
Q3 2024

Oct 25, 2024

BUY
$66.59 - $83.99 $163,145 - $205,775
2,450 New
2,450 $205,000
Q1 2024

Apr 18, 2024

SELL
$71.58 - $87.29 $41,874 - $51,064
-585 Reduced 10.52%
4,977 $364,000
Q4 2023

Feb 06, 2024

SELL
$73.27 - $83.09 $613,196 - $695,380
-8,369 Reduced 60.07%
5,562 $450,000
Q3 2023

Oct 18, 2023

BUY
$73.94 - $80.67 $109,283 - $119,230
1,478 Added 11.87%
13,931 $1.04 Million
Q2 2023

Jul 20, 2023

BUY
$76.01 - $86.7 $146,167 - $166,724
1,923 Added 18.26%
12,453 $959,000
Q1 2023

May 01, 2023

BUY
$77.31 - $88.08 $143,410 - $163,388
1,855 Added 21.38%
10,530 $873,000
Q4 2022

Jan 23, 2023

BUY
$62.32 - $89.47 $240,804 - $345,712
3,864 Added 80.32%
8,675 $0
Q3 2022

Oct 27, 2022

BUY
$59.54 - $68.01 $286,446 - $327,196
4,811 New
4,811 $297,000
Q4 2018

Feb 07, 2019

SELL
$60.54 - $79.0 $73,616 - $96,064
-1,216 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$71.28 - $78.92 $86,676 - $95,966
1,216 New
1,216 $95,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $123B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Measured Wealth Private Client Group, LLC Portfolio

Follow Measured Wealth Private Client Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Measured Wealth Private Client Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Measured Wealth Private Client Group, LLC with notifications on news.